Valuation UCB OTC Markets

Stocks

Market Closed - OTC Markets Other stock markets 14:00:32 2026-08-03 EDT			5-day change	1st Jan Change
263.84 ^USD	-2.16%		-8.34%	-10.13%

08-01	UCB SA, H1 2026 Earnings Call, Jul 30, 2026
07-31	AlphaValue/Baader Europe Upgrades UCB to Add, Trims PT	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	18,947	13,973	14,969	36,464	45,333	42,213	-	-
Change	-	-26.25%	7.12%	143.6%	24.32%	-6.88%	-	-
Enterprise Value (EV) ¹	19,807	15,973	17,146	37,918	45,326	42,334	40,231	37,649
Change	-	-19.36%	7.34%	121.15%	19.54%	-6.6%	-4.97%	-6.42%
P/E	17.9x	33.4x	44.8x	34.3x	29.1x	22.7x	18.6x	15x
PBR	2.32x	1.58x	1.67x	3.64x	4.18x	3.46x	3.09x	2.55x
PEG	-	-0.6x	-2.2x	0x	0.6x	1.2x	0.8x	0.6x
Capitalization / Revenue	3.28x	2.53x	2.85x	5.93x	5.86x	4.9x	4.36x	3.91x
EV / Revenue	3.43x	2.9x	3.26x	6.16x	5.86x	4.91x	4.16x	3.49x
EV / EBITDA	12.1x	12.7x	12.7x	25.7x	17.2x	14.3x	11x	8.7x
EV / EBIT	15x	23.7x	26.1x	45.4x	22.6x	17.5x	13.6x	10.3x
EV / FCF	15.6x	18.4x	38.5x	41.2x	24.6x	20.4x	15.3x	12x
FCF Yield	6.42%	5.43%	2.6%	2.43%	4.06%	4.9%	6.53%	8.34%
Dividend per Share ²	1.3	1.33	1.36	1.39	1.45	1.457	1.502	1.534
Rate of return	1.3%	1.81%	1.72%	0.72%	0.61%	0.65%	0.67%	0.69%
EPS ²	5.6	2.2	1.76	5.61	8.2	9.815	12.01	14.84
Distribution rate	23.2%	60.5%	77.3%	24.8%	17.7%	14.8%	12.5%	10.3%
Net sales ¹	5,777	5,517	5,252	6,152	7,741	8,618	9,682	10,786
EBITDA ¹	1,641	1,260	1,349	1,476	2,636	2,963	3,656	4,328
EBIT ¹	1,318	675	657	836	2,009	2,414	2,966	3,671
Net income ¹	1,058	418	343	1,065	1,558	1,847	2,326	2,859
Net Debt ¹	860	2,000	2,177	1,454	-7	121.8	-1,982	-4,564
Reference price ²	100.35	73.56	78.90	192.20	238.60	222.90	222.90	222.90
Nbr of stocks (in thousands)	188,812	189,959	189,721	189,720	189,996	190,663	-	-
Announcement Date	2/24/22	2/22/23	2/28/24	2/27/25	2/24/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
REGENERON PHARMACEUTICALS, INC.	18.09x	4.1x	9.64x	0.51%	76.15B
SAMSUNG BIOLOGICS CO.,LTD.	36.16x	12.36x	23.52x	-.--%	47.83B
CSL LIMITED	-46.27x	3.25x	9.61x	3.29%	41.37B
BIOGEN INC.	37.23x	3.36x	12.07x	-.--%	29.99B
INCYTE CORPORATION	55.01x	3.36x	26.05x	-.--%	24.23B
MODERNA, INC.	-6.33x	8.83x	-5.56x	-.--%	21.89B
INNOVENT BIOLOGICS, INC.	63.91x	6.11x	41.98x	-.--%	19.25B
SWEDISH ORPHAN BIOVITRUM AB	24.69x	5.29x	13.78x	-.--%	17.14B
BRIDGEBIO PHARMA, INC.	-36x	17.16x	-46.97x	-.--%	15.66B
Average	16.28x	7.09x	9.35x	0.42%	32.61B
Weighted average by Cap.	15.65x	6.44x	11.71x	0.6%